A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas

Clinical trial NCT05383352 · COMPLETED

Trial details

NCT number: NCT05383352
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma

Start date: 2022-05-30
Primary completion: 2024-05-27
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.